Literature DB >> 3852741

The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.

A W Dodds, S K Law, R R Porter.   

Abstract

The human complement component C4 occurs in many different forms which show big differences in their haemolytic activities. This phenomenon seems likely to be of considerable importance both physiologically and pathologically. C4 is coded by duplicated genes between HLA-D and HLA-B loci in the major histocompatibility complex in man. Several fold differences in haemolytic activity between products of the two loci C4-A and C4-B have been correlated with changes of six amino acid residues in this large protein of 1722 residues and with differences of several fold in the covalent binding of C4 to antibody-antigen aggregates. Some allotypes of one locus also differ markedly, notably C4-A6 which has 1/10th the haemolytic activity of other C4-A allotypes. A monoclonal antibody affinity column has been prepared which is able to separate C4-A from C4-B proteins and, using serum from an individual expressing only the C4-A6 allele at the C4-A locus, C4-A6 protein has been prepared. Investigation has shown C4-A6 to have the same reactivity as other C4-A allotypes except in the formation of the complex protease, C5 convertase. This protease is formed from C4, C2 and C3 and if C4-A6 is used it has approximately 1/5th the catalytic activity compared with other C4-A allotype. Allelic differences in sequence identified in C4 proteins so far are few and it is probable that the big difference in catalytic activity of C5 convertase is caused by very small changes in structure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852741      PMCID: PMC554491          DOI: 10.1002/j.1460-2075.1985.tb03920.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  26 in total

1.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

2.  The isolation and structure of C4, the fourth component of human complement.

Authors:  I Gigli; I von Zabern; R R Porter
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

3.  'Partial inhibition' of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants.

Authors:  C M Giles
Journal:  Vox Sang       Date:  1985       Impact factor: 2.144

4.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

5.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

6.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  A haemolytically non-active C4 gene product.

Authors:  P Teisberg; B Olaisen; R Nordhagen; E Thorsby; T Geddedahl
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

9.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

View more
  14 in total

Review 1.  The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Authors:  S K Law; A W Dodds
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

Review 2.  A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes.

Authors:  C Y Yu; R D Campbell; R R Porter
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.

Authors:  E Sim; A W Dodds; A Goldin
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 4.  Heat shock and the heat shock proteins.

Authors:  R H Burdon
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

5.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants.

Authors:  P M Schneider; M C Carroll; C A Alper; C Rittner; A S Whitehead; E J Yunis; H R Colten
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  The low C5 convertase activity of the C4A6 allotype of human complement component C4.

Authors:  T Kinoshita; A W Dodds; S K Law; K Inoue
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

7.  Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.

Authors:  J E Volanakis; Z B Zhu; F M Schaffer; K J Macon; J Palermos; B O Barger; R Go; R D Campbell; H W Schroeder; M D Cooper
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 8.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

9.  Effect of thiol compounds on human complement component C4.

Authors:  S Edmonds; A Gibb; E Sim
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

10.  The complement component C4 of mammals.

Authors:  A W Dodds; S K Law
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.